Related Experiment Video
Updated: Jan 13, 2026
Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers
Published on: March 3, 2023
Exploring Mesenchymal Stromal Cells as a Potential Therapy for Comorbid Osteoarthritis and Type 2 Diabetes Mellitus
Meiling Liu1,2, Siyi Xie1,2, Yajie Kong1,2
1Department of Orthopedics, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei Province, China, hebmu.edu.cn.
Background:
In recent years, the incidence rates of type 2 diabetes mellitus (T2DM) and osteoarthritis (OA) have increased significantly. Currently developed therapeutic approaches (e.g., pharmacotherapy) exhibit limited efficacy in the treatment of T2DM and OA, failing to fully restore joint function and pancreatic islet function. Mesenchymal stem cells (MSCs) have demonstrated substantial potential in repairing cartilage damage, reducing blood glucose levels, and other related aspects.
Objective:
This review aims to evaluate whether MSC therapy represents a potential therapeutic strategy for T2DM complicated with OA.
Summary:
This review highlights the association between OA and T2DM and summarizes the applications of MSCs in the treatment of OA and T2DM, the potential mechanisms of MSCs, as well as relevant therapeutic strategies.
Conclusion:
MSC therapy may exert therapeutic effects in models of T2DM complicated with OA. This approach is expected to serve as an innovative and effective therapeutic method, promoting research on stromal cells and their applications. However, further studies are still required to verify its safety and feasibility.
Insights
Mesenchymal stem cell (MSC) therapy shows promise for treating type 2 diabetes mellitus (T2DM) and osteoarthritis (OA) due to its regenerative potential. Further research is needed to confirm the safety and effectiveness of MSCs for these interconnected conditions.
Area of Science:
- Regenerative Medicine
- Endocrinology
- Orthopedics
Background:
- Type 2 diabetes mellitus (T2DM) and osteoarthritis (OA) incidence is rising globally.
- Current treatments for T2DM and OA have limited efficacy and do not fully restore organ function.
- Mesenchymal stem cells (MSCs) show potential for cartilage repair and glucose regulation.
Purpose of the Study:
- To evaluate Mesenchymal stem cell (MSC) therapy as a potential treatment for type 2 diabetes mellitus (T2DM) with co-occurring osteoarthritis (OA).
Main Methods:
- This review synthesizes existing research on the association between OA and T2DM.
- It summarizes the therapeutic applications and potential mechanisms of MSCs in treating OA and T2DM.
- Relevant therapeutic strategies involving MSCs are discussed.
Main Results:
- MSC therapy demonstrates potential therapeutic effects in preclinical models of T2DM complicated with OA.
- This approach may offer an innovative treatment strategy for these conditions.
Conclusions:
- MSC therapy presents a promising avenue for treating T2DM with OA.
- Further investigation into the safety and feasibility of MSC therapy is essential before clinical application.
More Related Videos
09:48Large-Scale Preparation of Synovial Fluid Mesenchymal Stem Cell-Derived Exosomes by 3D Bioreactor Culture
Published on: July 26, 2022
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
Related Concept Videos
01:19Mesenchymal Stem Cells
01:22Diabetes Mellitus: Type 2 and Gestational